ITGB3 and nasopharyngeal carcinoma: Moreover, cilengitide treatment and ITGB3 knockout inverted the P-EVs- and ITGB3-enhanced single-cell-derived clone growth and clonogenic ability of NPC cells (Figure 2H and Figure 2I).